TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
UCB Pharma AS
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
227,542
|
230,808
|
250,217 |
Financial expenses |
3,239
|
1,810
|
1,168 |
Earnings before taxes |
5,931
|
6,944
|
7,869 |
Total assets |
148,758
|
126,234
|
135,197 |
Current assets |
148,581
|
126,094
|
135,103 |
Current liabilities |
115,647
|
97,854
|
106,871 |
Equity capital |
33,111
|
28,380
|
28,325 |
- share capital |
495
![]() |
495
![]() |
495 |
Employees (average) | 9 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
22.3%
|
22.5%
|
21.0% |
Turnover per employee | 25,645 | ||
Profit as a percentage of turnover |
2.6%
|
3.0%
|
3.1% |
Return on assets (ROA) |
6.2%
|
6.9%
|
6.7% |
Current ratio |
128.5%
|
128.9%
|
126.4% |
Return on equity (ROE) |
17.9%
|
24.5%
|
27.8% |
Change turnover |
-3,266
|
-19,409
|
-6,706 |
Change turnover % |
-1%
|
-8%
|
-3% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.